Niu MM - Search Results

1

Discovery of a Potent PLK1-PBD Small-Molecule Inhibitor as an Anticancer Drug Candidate through Structure-Based Design.

Zhou Y, Yan F, Huo X, Niu MM. Zhou Y, et al. Among authors: niu mm. Molecules. 2019 Nov 28;24(23):4351. doi: 10.3390/molecules24234351. Molecules. 2019. PMID: 31795214 Free PMC article.

2

Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors.

Niu M, Dong F, Tang S, Fida G, Qin J, Qiu J, Liu K, Gao W, Gu Y. Niu M, et al. PLoS One. 2013 Dec 10;8(12):e82360. doi: 10.1371/journal.pone.0082360. eCollection 2013. PLoS One. 2013. PMID: 24340020 Free PMC article.

3

Design and synthesis of an immobilized metal affinity chromatography and metal oxide affinity chromatography hybrid material for improved phosphopeptide enrichment.

Yang DS, Ding XY, Min HP, Li B, Su MX, Niu MM, Di B, Yan F. Yang DS, et al. Among authors: niu mm. J Chromatogr A. 2017 Jul 7;1505:56-62. doi: 10.1016/j.chroma.2017.05.025. Epub 2017 May 10. J Chromatogr A. 2017. PMID: 28533032

4

Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.

Min H, Niu M, Zhang W, Yan J, Li J, Tan X, Li B, Su M, Di B, Yan F. Min H, et al. PLoS One. 2017 Nov 9;12(11):e0187971. doi: 10.1371/journal.pone.0187971. eCollection 2017. PLoS One. 2017. PMID: 29121121 Free PMC article.

5

Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors.

Lin TY, Min HP, Jiang C, Niu MM, Yan F, Xu LL, Di B. Lin TY, et al. Among authors: niu mm. Bioorg Med Chem. 2018 Jul 23;26(12):3429-3437. doi: 10.1016/j.bmc.2018.05.014. Epub 2018 May 14. Bioorg Med Chem. 2018. PMID: 29807699

6

Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity.

Zhou Y, Di B, Niu MM. Zhou Y, et al. Among authors: niu mm. Molecules. 2019 Sep 1;24(17):3181. doi: 10.3390/molecules24173181. Molecules. 2019. PMID: 31480625 Free PMC article.

7

Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors.

Zhou Y, Tang S, Chen T, Niu MM. Zhou Y, et al. Among authors: niu mm. Molecules. 2019 Nov 22;24(23):4258. doi: 10.3390/molecules24234258. Molecules. 2019. PMID: 31766720 Free PMC article.

8

Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain.

Yan F, Liu G, Chen T, Fu X, Niu MM. Yan F, et al. Among authors: niu mm. Molecules. 2019 Dec 27;25(1):107. doi: 10.3390/molecules25010107. Molecules. 2019. PMID: 31892137 Free PMC article.

9

An NRP1/MDM2-Targeted D-Peptide Supramolecular Nanomedicine for High-Efficacy and Low-Toxic Liver Cancer Therapy.

Zhou Y, Chen Y, Tan Y, Hu R, Niu MM. Zhou Y, et al. Among authors: niu mm. Adv Healthc Mater. 2021 May;10(9):e2002197. doi: 10.1002/adhm.202002197. Epub 2021 Mar 9. Adv Healthc Mater. 2021. PMID: 33690977

10

A Supramolecular Nanomedicine Based on Bendamustine and MDM2-Targeted D-peptide Inhibitor for Breast Cancer Therapy.

Zhou Y, Chen Y, Huang X, Tan Y, Hu R, Li C, Niu MM. Zhou Y, et al. Among authors: niu mm. Adv Healthc Mater. 2021 Nov;10(21):e2100980. doi: 10.1002/adhm.202100980. Epub 2021 Sep 23. Adv Healthc Mater. 2021. PMID: 34558228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters